Chinese investigators evaluated 15 years' worth of data from more than 18,000 adult men in the U.S. to better characterize OAB and its risk factors. The overall presence of OAB increased significantly ...

Men with overactive bladder had significant 95% reduced odds of urinary tract cancers compared with a reference group of men with urolithiasis, after adjusting for age. Overactive bladder (OAB) is ...

In a trial, vibegron 75 mg once daily meaningfully improved key OAB symptoms in men receiving benign prostatic hyperplasia treatments. Vibegron reduces storage symptoms of overactive bladder (OAB) in ...

Please provide your email address to receive an email when new articles are posted on . The proportion of men with overactive bladder increased significantly from 2015 to 2020. Results showed ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms receiving pharmacologic therapy for benign prostatic ...

Aggression was more prevalent in men with OAB or LUTS than in men without either condition and contributed to poorer quality of life. The difference in quality of life was statistically significant ...

Combining pelvic floor exercises with behavioral therapy could be more effective than current medical treatments at helping men with frequent urges to urinate, new research in men has found. The ...

Structured behavioral therapy focused on pelvic floor muscle exercise was noninferior to treatment with solifenacin for alleviating overactive bladder symptoms in patients with Parkinson’s disease (PD ...

DEAR DR. ROACH: I am 71 and began having urinary issues due to benign prostatic hyperplasia (BPH) many years ago. I took alpha blockers (Flomax, double Flomax and tadalifil), which didn’t provide any ...